Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per year, Susvimo ...

or diabetic retinopathy. These conditions become more common with age and can make daily tasks like cooking and walking harder. But optometrists who specialize in low vision—reduced vision that can’t ...

Vision problems sometimes go beyond what can be corrected with a stronger prescription for glasses ... degeneration (AMD), glaucoma, or diabetic retinopathy. These conditions become more common ...

There’s no release timeline, but Samsung’s TM Roh tells Bloomberg that the company will try to launch the glasses ‘as soon as possible.’ There’s no release timeline, but Samsung’s TM ...

as well as in augmented and virtual reality, where the company has invested heavily for years despite lagging consumer adoption. Like Meta's Ray-Ban collection of smart glasses, the Oakley version ...

Having poor control of blood sugar, retinopathy (damage to the light-sensing tissue at the back of the eye), or neuropathy (nerve damage) are risk factors associated with increased rates of diabetic ...

Before coming to The Verge, she worked for Gizmodo and PC Magazine. Meta may be releasing new Oakley-branded smart glasses later this year, according to a new Bloomberg report. The Oakley-branded ...

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual ... the treatment of diabetic peripheral ...

In advance of topline data from the Phase 2b PROGRESS trial anticipated later this quarter, the event will offer an in-depth overview on LX9211 for the treatment of diabetic peripheral neuropathic ...